A revolution in apoptosis: from a nucleocentric to a mitochondriocentric perspective

CATHERINE Brenner , ISABEL Marzo , GUIDO Kroemer
Experimental gerontology 33 ( 6) 543 -553

48
1998
Complejos de oro(III) con ligandos derivados del ácido niflúmico con potencial actividad biológica

M. Dolores Villacampa , Isabel Marzo , Bárbara Palacino-Blázquez , Alejandro Gutiérrez

2014
Proteasome Activation Occurs at an Early, Premitochondrial Step of Thymocyte Apoptosis

Guido Kroemer , Santos A. Susin , Naoufal Zamzami , Bruno Dallaporta
Journal of Immunology 161 ( 1) 35 -40

83
1998
Potassium Leakage During the Apoptotic Degradation Phase

Guido Kroemer , Santos A. Susin , Nathanael Larochette , Naoufal Zamzami
Journal of Immunology 160 ( 11) 5605 -5615

220
1998
Bimetallic complexes as cooperative partners in cell imaging and cancer therapy

Vanesa Fernández-Moreira , Isabel Marzo , M. Concepción Gimeno

2015
Re(I) and Re(I)/Au(I) complexes for cell imaging and therapy applications

Vanesa Fernández-Moreira , Isabel Marzo , Andrés Luengo , M. Concepción Gimeno

2016
Heterometallic Re(I)/Au(I) complexes as theranostic agents

Vanesa Fernández-Moreira , Isabel Marzo , Andrés Luengo , M. Concepción Gimeno

2017
Multifunctional Heterometallic IrIII -AuI Probes as Promising Anticancer and Antiangiogenic Agents.

Vanesa Fernández-Moreira , M Concepción Gimeno , Isabel Marzo , Marta Redrado
Chemistry: A European Journal

2021
mtDNA‐depleted U937 cells are sensitive to TNF and Fas‐mediated cytototxicity

Susana Gamen , Alberto Anel , Julio Montoya , Isabel Marzo
FEBS Letters 376 15 -18

29
1995
CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells

Susana Gamen , Isabel Marzo , Alberto Anel , Andrés Piñeiro
FEBS Letters 390 ( 2) 233 -237

76
1996
Bcl-2 family members as molecular targets in cancer therapy

Isabel Marzo , Javier Naval
Biochemical Pharmacology 76 ( 8) 939 -946

70
2008
Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis

Patricia Balsas , Nuria López-Royuela , Patricia Galán-Malo , Alberto Anel
Biochemical Pharmacology 77 ( 5) 804 -812

46
2009
Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells.

Nuria López-Royuela , Patricia Pérez-Galán , Patricia Galán-Malo , Victor J. Yuste
Biochemical Pharmacology 79 ( 12) 1746 -1758

24
2010
Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer

Luis Martinez-Lostao , Isabel Marzo , Alberto Anel , Javier Naval
Biochemical Pharmacology 83 ( 11) 1475 -1483

44
2012
Luminescent Re(I)/Au(I) species as selective anticancer agents for HeLa cells

Andrés Luengo , Marta Redrado , Isabel Marzo , Vanesa Fernández-Moreira
Inorganic Chemistry 59 ( 13) 8960 -8970

7
2020
The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins.

Isabel Marzo , Catherine Brenner , Naoufal Zamzami , Santos A. Susin
Journal of Experimental Medicine 187 ( 8) 1261 -1271

646
1998
Mitochondrial Release of Caspase-2 and -9 during the Apoptotic Process

Santos A. Susin , Hans K. Lorenzo , Naoufal Zamzami , Isabel Marzo
Journal of Experimental Medicine 189 ( 2) 381 -394

942
1999
Gold(I) thiolates containing amino acid moieties. Cytotoxicity and structure-activity relationship studies

Alejandro Gutiérrez , Lucia Gracia-Fleta , Isabel Marzo , Carlos Cativiela
Dalton Transactions 43 ( 45) 17054 -17066

27
2014
Apo2L/TRAIL is an indirect mediator of apoptosis induced by interferon-α in human myeloma cells

Maria Gómez-Benito , Patricia Balsas , Alberto Bosque , Alberto Anel
FEBS Letters 579 ( 27) 6217 -6222

24
2005
Individual Variation of Scavenger Receptor Expression in Human Macrophages with Oxidized Low-Density Lipoprotein Is Associated with a Differential Inflammatory Response

Paula Martín-Fuentes , Fernando Civeira , Delia Recalde , Angel Luis García-Otín
Journal of Immunology 179 ( 5) 3242 -3248

63
2007